| Role of the Alanine at Position 363 of Cytochrome P450 2B2 in Influencing the NADPH- and Hydroperoxide-Supported Activities | journal | February 1998 | 
    | In vitro comparative assessment of different viability assays in Acanthamoeba castellanii and Acanthamoeba polyphaga trophozoites | journal | September 2013 | 
    | Cloning and characterization of the Dictyostelium discoideum cycloartenol synthase cDNA | journal | March 2000 | 
    | Oteseconazole: First Approval | journal | June 2022 | 
    | Acanthamoeba keratitis with live isolates treated with cryosurgery and fluconazole | journal | June 1999 | 
    | The Carbon Monoxide-binding Pigment of Liver Microsomes | journal | July 1964 | 
    | Anti-amoebic potential of azole scaffolds and nanoparticles against pathogenic Acanthamoeba | journal | November 2020 | 
    | Sterol 14α-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms | journal | March 2007 | 
    | Ligand tunnels in T. brucei and human CYP51: Insights for parasite-specific drug design | journal | January 2016 | 
    | Sterol 14α-Demethylase as a Potential Target for Antitrypanosomal Therapy: Enzyme Inhibition and Parasite Cell Growth | journal | November 2007 | 
    | Acanthamoeba and its pathogenic role in granulomatous amebic encephalitis | journal | January 2020 | 
    | A simple method for the determination of reduction potentials in heme proteins | journal | January 2014 | 
    | Sequence variation in CYP51A from the Y strain of Trypanosoma cruzi alters its sensitivity to inhibition | journal | September 2014 | 
    | Isavuconazole and voriconazole inhibition of sterol 14α-demethylases (CYP51) from Aspergillus fumigatus and Homo sapiens | journal | October 2019 | 
    | CYP51 structures and structure-based development of novel, pathogen-specific inhibitory scaffolds | journal | December 2012 | 
    | Processive kinetics in the three-step lanosterol 14α-demethylation reaction catalyzed by human cytochrome P450 51A1 | journal | July 2023 | 
    | Acanthamoeba spp. as a universal host for pathogenic microorganisms: One bridge from environment to host virulence | journal | December 2016 | 
    | A convergent, scalable and stereoselective synthesis of azole CYP51 inhibitors | journal | November 2017 | 
    | Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals | journal | August 2007 | 
    | CYP51 as drug targets for fungi and protozoan parasites: past, present and future | journal | April 2018 | 
    | Relaxed Substrate Requirements of Sterol 14α-Demethylase from Naegleria fowleri Are Accompanied by Resistance to Inhibition | journal | November 2021 | 
    | Sterol 14α-Demethylase Structure-Based Design of VNI (( R )- N -(1-(2,4-Dichlorophenyl)-2-(1 H -imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide)) Derivatives To Target Fungal Infections: Synthesis, Biological Evaluation, and Crystallographic Analysis | journal | June 2018 | 
    | Sterol 14α-Demethylase Structure-Based Optimization of Drug Candidates for Human Infections with the Protozoan Trypanosomatidae | journal | November 2018 | 
    | Validation of Human Sterol 14α-Demethylase (CYP51) Druggability: Structure-Guided Design, Synthesis, and Evaluation of Stoichiometric, Functionally Irreversible Inhibitors | journal | October 2019 | 
    | CYP51 from Trypanosoma brucei Is Obtusifoliol-Specific † | journal | August 2004 | 
    | Structural Basis for Rational Design of Inhibitors Targeting Trypanosoma cruzi Sterol 14α-Demethylase: Two Regions of the Enzyme Molecule Potentiate Its Inhibition | journal | July 2014 | 
    | A randomized masked pilot clinical trial to compare the efficacy of topical 1% voriconazole ophthalmic solution as monotherapy with combination therapy of topical 0.02% polyhexamethylene biguanide and 0.02% chlorhexidine in the treatment of Acanthamoeba keratitis | journal | July 2020 | 
    | Characterisation of sterol biosynthesis and validation of 14α-demethylase as a drug target in Acanthamoeba | journal | August 2017 | 
    | Unravelling the role of transient redox partner complexes in P450 electron transfer mechanics | journal | September 2022 | 
    | Sterol biosynthesis de nova via cycloartenol by the soil amoeba Acanthamoeba polyphaga | journal | November 1985 | 
    | An update onAcanthamoebakeratitis: diagnosis, pathogenesis and treatment | journal | January 2015 | 
    | Sterol phylogenesis and algal evolution. | journal | October 1990 | 
    | Crystal Structures of Trypanosoma brucei Sterol 14α-Demethylase and Implications for Selective Treatment of Human Infections | journal | November 2009 | 
    | Structural Insights into Inhibition of Sterol 14α-Demethylase in the Human Pathogen Trypanosoma cruzi | journal | June 2010 | 
    | Complexes of Trypanosoma cruzi Sterol 14α-Demethylase (CYP51) with Two Pyridine-based Drug Candidates for Chagas Disease : STRUCTURAL BASIS FOR PATHOGEN SELECTIVITY | journal | September 2013 | 
    | Structure-Functional Characterization of Cytochrome P450 Sterol 14α-Demethylase (CYP51B) from Aspergillus fumigatus and Molecular Basis for the Development of Antifungal Drugs | journal | August 2015 | 
    | Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis | journal | March 2017 | 
    | Binding of a physiological substrate causes large-scale conformational reorganization in cytochrome P450 51 | journal | October 2018 | 
    | VNI Cures Acute and Chronic Experimental Chagas Disease | journal | January 2013 | 
    | VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis | journal | April 2015 | 
    | Concerning P450 Evolution: Structural Analyses Support Bacterial Origin of Sterol 14α-Demethylases | journal | October 2020 | 
    | Paralog Re-Emergence: A Novel, Historically Contingent Mechanism in the Evolution of Antimicrobial Resistance | journal | April 2014 | 
    | Fatal Granulomatous Amoebic Encephalitis Caused by Acanthamoeba in a Patient With Kidney Transplant: A Case Report | journal | July 2015 | 
    | Microsomal P450s Use Specific Proline--Rich Sequences for Efficient Folding, but Not for Maintenance of the Folded Structure | journal | February 2001 | 
    | Successful Treatment of Chronic Stromal Acanthamoeba Keratitis With Oral Voriconazole Monotherapy | journal | September 2010 | 
    | Granulomatous amoebic encephalitis: ghost response of an immunocompromised host? | journal | December 2014 | 
    | Features and development of Coot | journal | March 2010 | 
    | Overview of the CCP 4 suite and current developments | journal | March 2011 | 
    | Data processing and analysis with the autoPROC toolbox | journal | March 2011 | 
    | How good are my data and what is the resolution? | journal | June 2013 | 
    | Unravelling the interactions of the environmental hostAcanthamoeba castellaniiwith fungi through the recognition by mannose‐binding proteins | journal | June 2019 | 
    | The action of the systemic fungicides tridemorph and fenpropimorph on sterol biosynthesis by the soil amoeba Acanthamoeba polyphaga | journal | April 1987 | 
    | Bacterial Endosymbionts of Free‐living Amoebae1 | journal | September 2004 | 
    | Characterization of the sterol 14α-demethylases of Fusarium graminearum identifies a novel genus-specific CYP51 function | journal | February 2013 | 
    | Pandoraviruses: Amoeba Viruses with Genomes Up to 2.5 Mb Reaching That of Parasitic Eukaryotes | journal | July 2013 | 
    | Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14α-Demethylase (CYP51) | journal | August 2015 | 
    | Minimal Cerebrospinal Fluid Concentration of Miltefosine despite Therapeutic Plasma Levels during the Treatment of Amebic Encephalitis | journal | December 2019 | 
    | The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme | journal | September 2014 | 
    | Acanthamoeba spp. as Agents of Disease in Humans | journal | April 2003 | 
    | Identification of Two Different 14-α Sterol Demethylase-Related Genes ( cyp51A and cyp51B ) in Aspergillus fumigatus and Other Aspergillus species | journal | July 2001 | 
    | Crystal Structure of the New Investigational Drug Candidate VT-1598 in Complex with Aspergillus fumigatus Sterol 14α-Demethylase Provides Insights into Its Broad-Spectrum Antifungal Activity | journal | May 2017 | 
    | Impact of the Major Candida glabrata Triazole Resistance Determinants on the Activity of the Novel Investigational Tetrazoles VT-1598 and VT-1161 | journal | October 2019 | 
    | Clinical Candidate VT-1161's Antiparasitic Effect In Vitro , Activity in a Murine Model of Chagas Disease, and Structural Characterization in Complex with the Target Enzyme CYP51 from Trypanosoma cruzi | journal | December 2015 | 
    | Biology and pathogenesis of Acanthamoeba | journal | January 2012 | 
    | Human sterol 14α-demethylase as a target for anticancer chemotherapy: towards structure-aided drug design | journal | June 2016 | 
    | Sterol methyltransferase a target for anti-amoeba therapy: towards transition state analog and suicide substrate drug design | journal | December 2017 | 
    | Novel antifungal agents in clinical trials | journal | June 2021 | 
    | Successful Treatment of DisseminatedAcanthamoebasp. Infection with Miltefosine | journal | November 2008 | 
    | Hijacking Chemical Reactions of P450 Enzymes for Altered Chemical Reactions and Asymmetric Synthesis | journal | December 2022 | 
    | A Systematic Review of Intracellular Microorganisms within Acanthamoeba to Understand Potential Impact for Infection | journal | February 2021 | 
    | Environmental (Saprozoic) Pathogens of Engineered Water Systems: Understanding Their Ecology for Risk Assessment and Management | journal | June 2015 | 
    | Gold Nanoparticles Conjugation Enhances Antiacanthamoebic Properties of Nystatin, Fluconazole and Amphotericin B | journal | January 2019 | 
    | Treatment of Granulomatous Amoebic Encephalitis with Voriconazole and Miltefosine in an Immunocompetent Soldier | journal | October 2012 | 
    | Acanthamoeba Infection in a Drowning Child | journal | May 2016 | 
    | Amoebicidal effect of Fluconazole and Verapamil together against trophozoites and cysts of Acanthamoeba castellanii | journal | June 2023 | 
    | Acanthamoeba Keratitis: A Single-Institution Series of Four Cases With Literature Review | journal | January 2022 |